Strong exposure to the decentralized clinical trial ecosystem and the operational realities across sponsors, CROs, and research sites. Opportunity to work closely with founders and leadership while learning quickly in a fast-moving healthcare SaaS environment.
Cons
Company was still refining product positioning, ICP focus, and commercialization strategy while scaling. At times this created unclear expectations, broad targeting, and challenges building a repeatable sales motion.
